Needle-Free Drug Delivery Devices Market Size & Share 2024-2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Needle-Free Drug Delivery Devices Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $25.88 billion In 2028 At A CAGR Of 11.6% :

The needle-free drug delivery devices market size has grown exponentially in recent years. It will grow from $14.99 billion in 2023 to $16.70 billion in 2024 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to the increased prevalence of chronic diseases, increased demand for painless drug delivery methods, high geriatric population, emphasis on patient compliance and safety, regulatory support for needle-free technologies, and expanded pharmaceutical industry.

The needle-free drug delivery devices market size is expected to see exponential growth in the next few years. It will grow to $25.88 billion in 2028 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to increasing demand for painless medication administration, growing emphasis on patient-centric healthcare solutions, expanding applications in pediatric and geriatric populations, rising prevalence of chronic diseases necessitating frequent injections, technological advancements enhancing device efficiency and usability, expanding access to healthcare in emerging markets, and growing investments in research and development for innovative delivery systems. Major trends in the forecast period include increased adoption of wearable and connected devices, the emergence of novel microfluidic technologies, a growing focus on pediatric-friendly needle-free solutions, the integration of artificial intelligence and machine learning algorithms, and expanding applications in home healthcare settings.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp

Needle-Free Drug Delivery Devices Market Major Segments
The needle-free drug delivery devices market covered in this report is segmented -

1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches, Other Device Types
2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications
3) By End-User: Hospitals And Clinics, Home Healthcare

Key Driver - Genitourinary Disease-Driven Growth In The Vulvodynia Treatment Market

The increasing prevalence of diabetes is expected to propel the growth of the needle-free drug delivery device market going forward. Diabetes presents as a persistent health issue marked by high blood sugar levels, stemming from inadequate insulin production or the body's ineffective utilization of insulin. Diabetes is on the rise due to sedentary lifestyles, unhealthy dietary habits, genetic predisposition, urbanization, and aging populations, compounded by limited access to healthcare and rising obesity rates worldwide. Needle-free drug delivery devices provide an alternative to conventional injections for insulin administration in diabetes care. It uses technologies such as jet injectors or transdermal patches that deliver insulin through the skin without needles, alleviating the discomfort and anxiety often linked with injections and enhancing comfort levels. For instance, in July 2021, according to the International Diabetes Federation, a Belgium-based organization, the projected number of individuals living with diabetes is expected to increase to 643 million by 2030 and 783 million by 2045. Therefore, the increasing prevalence of diabetes is driving the growth of the needle-free drug delivery device market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=15615&type=smp

Prominent Trend - Advancements In Dual Chamber Inhalers Revolutionize The Needle-Free Drug Delivery Market

Major companies operating in the needle-free drug delivery device market are focusing on advanced solutions, such as dual chamber inhalers, to enhance the efficacy and ease of administration and cater to the evolving needs of patients and healthcare providers. A dual-chamber inhaler is a device with two compartments that can hold different medications separately. This design allows for the combination of multiple drugs in a single inhaler, streamlining treatment and improving convenience for patients. For instance, in April 2024, Berry Global, a US-based plastic manufacturing company, introduced the BerryHaler, a cutting-edge dry powder inhaler (DPI) designed to revolutionize patient-centered healthcare solutions. This dual-chamber inhaler boasts a dose counter, ensuring precise medication administration. Its all-plastic construction, devoid of any metal parts, makes it ideal for complex inhalation treatments, simplifying dosage and combining multiple drugs effectively. The advanced features include a bi-directional mouthpiece cover for convenience and hygiene, along with audible signals to indicate proper usage. The integrated dose counter aids in monitoring medication usage accurately, preventing dosage errors.

Needle-Free Drug Delivery Devices Market Players
Major companies operating in the needle-free drug delivery devices market are Pfizer Inc., Merck & Co. Inc., Bayer AG, 3M Company, Medtronic plc, Novo Nordisk AS, Becton, Dickinson and Company, Endo International plc, Insulet Corporation, Purdue Pharma L.P., Antares Pharma Inc., MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, Inovio Pharmaceuticals, Inc., National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/needle-free-drug-delivery-devices-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the needle-free drug delivery devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Needle-Free Drug Delivery Devices Market Report Structure
3. Needle-Free Drug Delivery Devices Market Trends And Strategies
4. Needle-Free Drug Delivery Devices Market - Macro Economic Scenario
5. Needle-Free Drug Delivery Devices Market Size And Growth
…..
27. Needle-Free Drug Delivery Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.